---
title: Treatment pattern and outcomes of re-induction therapy prior to stem cell transplantation
  in patients with relapsed/refractory multiple myeloma in Germany
date: '2024-03-14'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38480852/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240314180555&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: There are limited data guiding choice of re-induction therapies for patients
  with relapsed/refractory multiple myeloma (RRMM) prior to stem cell transplantation
  (SCT). We performed a retrospective medical chart review of 171 patients with RRMM
  in Germany who received re-induction therapy in second line (78%; n = 134) or third
  line (22%; n = 37) prior to re-SCT. Index therapy was defined as first completed
  re-induction therapy for planned myeloablative conditioning and SCT in second/third
  ...
disable_comments: true
---
There are limited data guiding choice of re-induction therapies for patients with relapsed/refractory multiple myeloma (RRMM) prior to stem cell transplantation (SCT). We performed a retrospective medical chart review of 171 patients with RRMM in Germany who received re-induction therapy in second line (78%; n = 134) or third line (22%; n = 37) prior to re-SCT. Index therapy was defined as first completed re-induction therapy for planned myeloablative conditioning and SCT in second/third ...